Gregory Bailey - Net Worth and Insider Trading

Gregory Bailey Net Worth

The estimated net worth of Gregory Bailey is at least $167 Million dollars as of 2024-09-13. Gregory Bailey is the Director of Medivation Inc and owns about 894,660 shares of Medivation Inc (MDVN) stock worth over $73 Million. Gregory Bailey is the Director of Biohaven Ltd and owns about 1,615,071 shares of Biohaven Ltd (BHVN) stock worth over $58 Million. Gregory Bailey is also the Director of Biohaven Pharmaceutical Holding Co Ltd and owns about 2,583,658 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) stock worth over $36 Million. Besides these, Gregory Bailey also holds Serina Therapeutics Inc (SER) . Details can be seen in Gregory Bailey's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gregory Bailey has not made any transactions after 2024-08-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Gregory Bailey

To

Gregory Bailey Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gregory Bailey owns 5 companies in total, including Biohaven Pharmaceutical Holding Co Ltd (BHVN) , AgeX Therapeutics Inc (AGE) , and Medivation Inc (MDVN) among others .

Click here to see the complete history of Gregory Bailey’s form 4 insider trades.

Insider Ownership Summary of Gregory Bailey

Ticker Comapny Transaction Date Type of Owner
BHVN Biohaven Pharmaceutical Holding Co Ltd 2022-08-19 director
AGE AgeX Therapeutics Inc 2018-11-27 director
MDVN Medivation Inc 2012-10-30 director
LIMIT LIMIT 2006-04-13 director
LIMIT LIMIT 2024-05-13 director

Gregory Bailey Latest Holdings Summary

Gregory Bailey currently owns a total of 4 stocks. Among these stocks, Gregory Bailey owns 894,660 shares of Medivation Inc (MDVN) as of October 24, 2012, with a value of $73 Million and a weighting of 43.56%. Gregory Bailey owns 1,615,071 shares of Biohaven Ltd (BHVN) as of May 13, 2024, with a value of $58 Million and a weighting of 34.52%. Gregory Bailey also owns 2,583,658 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) as of August 19, 2022, with a value of $36 Million and a weighting of 21.75%. The other 1 stocks Serina Therapeutics Inc (SER) have a combined weighting of 0.18% among all his current holdings.

Latest Holdings of Gregory Bailey

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MDVN Medivation Inc 2012-10-24 894,660 81.44 72,861,110
BHVN Biohaven Ltd 2024-05-13 1,615,071 35.75 57,738,788
BHVN Biohaven Pharmaceutical Holding Co Ltd 2022-08-19 2,583,658 14.08 36,377,905
SER Serina Therapeutics Inc 2024-08-20 47,582 6.18 293,985

Holding Weightings of Gregory Bailey


Gregory Bailey Form 4 Trading Tracker

According to the SEC Form 4 filings, Gregory Bailey has made a total of 0 transactions in Medivation Inc (MDVN) over the past 5 years. The most-recent trade in Medivation Inc is the sale of 33,600 shares on October 24, 2012, which brought Gregory Bailey around $900,480.

According to the SEC Form 4 filings, Gregory Bailey has made a total of 5 transactions in Biohaven Ltd (BHVN) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Biohaven Ltd is the acquisition of 15,000 shares on May 13, 2024, which cost Gregory Bailey around $512,850.

According to the SEC Form 4 filings, Gregory Bailey has made a total of 7 transactions in Biohaven Pharmaceutical Holding Co Ltd (BHVN) over the past 5 years, including 1 buys and 6 sells. The most-recent trade in Biohaven Pharmaceutical Holding Co Ltd is the acquisition of 38,000 shares on August 19, 2022, which cost Gregory Bailey around $6 Million.

More details on Gregory Bailey's insider transactions can be found in the Insider Trading History of Gregory Bailey table.

Insider Trading History of Gregory Bailey

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gregory Bailey Trading Performance

GuruFocus tracks the stock performance after each of Gregory Bailey's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gregory Bailey is 9.29%. GuruFocus also compares Gregory Bailey's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gregory Bailey within 3 months outperforms 5 times out of 12 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Gregory Bailey's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Gregory Bailey

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
3 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 1.08 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -1.14 LIMIT LIMIT LIMIT LIMIT LIMIT

Gregory Bailey Ownership Network

Ownership Network List of Gregory Bailey

No Data

Ownership Network Relation of Gregory Bailey

Insider Network Chart

Gregory Bailey Owned Company Details

What does Biohaven Pharmaceutical Holding Co Ltd do?

Who are the key executives at Biohaven Pharmaceutical Holding Co Ltd?

Gregory Bailey is the director of Biohaven Pharmaceutical Holding Co Ltd. Other key executives at Biohaven Pharmaceutical Holding Co Ltd include VP & Chief Accounting Officer George C. Clark , Chief Medical Officer Elyse Stock , and Chief Financial Officer James Engelhart .

Biohaven Pharmaceutical Holding Co Ltd (BHVN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Biohaven Pharmaceutical Holding Co Ltd (BHVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Biohaven Pharmaceutical Holding Co Ltd Insider Transactions

No Available Data

Gregory Bailey Mailing Address

Above is the net worth, insider trading, and ownership report for Gregory Bailey. You might contact Gregory Bailey via mailing address: 4 A Chesham Street, London X0 Sw1x8dt.

Discussions on Gregory Bailey

No discussions yet.